{"explains":[],"count":17,"quotes":[{"exchange":"NYQ","shortname":"Novartis AG","quoteType":"EQUITY","symbol":"NVS","index":"quotes","score":21440.0,"typeDisp":"Equity","longname":"Novartis AG","exchDisp":"NYSE","sector":"Healthcare","sectorDisp":"Healthcare","industry":"Drug Manufacturers—General","industryDisp":"Drug Manufacturers—General","dispSecIndFlag":true,"isYahooFinance":true},{"exchange":"EBS","shortname":"NOVARTIS N","quoteType":"EQUITY","symbol":"NOVN.SW","index":"quotes","score":20310.0,"typeDisp":"Equity","longname":"Novartis AG","exchDisp":"Swiss","sector":"Healthcare","sectorDisp":"Healthcare","industry":"Drug Manufacturers—General","industryDisp":"Drug Manufacturers—General","isYahooFinance":true},{"exchange":"PNK","shortname":"NOVARTIS AG","quoteType":"EQUITY","symbol":"NVSEF","index":"quotes","score":20007.0,"typeDisp":"Equity","longname":"Novartis AG","exchDisp":"OTC Markets","sector":"Healthcare","sectorDisp":"Healthcare","industry":"Drug Manufacturers—General","industryDisp":"Drug Manufacturers—General","isYahooFinance":true},{"exchange":"LSE","shortname":"NOVARTIS AG NOVARTIS ADR REPRES","quoteType":"EQUITY","symbol":"0K9E.L","index":"quotes","score":20005.0,"typeDisp":"Equity","longname":"Novartis AG","exchDisp":"London","isYahooFinance":true},{"exchange":"CXE","shortname":"Novartis AG","quoteType":"EQUITY","symbol":"NOVNZ.XC","index":"quotes","score":20005.0,"typeDisp":"Equity","longname":"Novartis AG","exchDisp":"CXE","isYahooFinance":true},{"exchange":"MEX","shortname":"NOVARTIS AG","quoteType":"EQUITY","symbol":"NVSN.MX","index":"quotes","score":20004.0,"typeDisp":"Equity","longname":"Novartis AG","exchDisp":"Mexico","sector":"Healthcare","sectorDisp":"Healthcare","industry":"Drug Manufacturers—General","industryDisp":"Drug Manufacturers—General","isYahooFinance":true},{"exchange":"FRA","shortname":"NOVARTIS NAM. ADR 1","quoteType":"EQUITY","symbol":"NOTA.F","index":"quotes","score":20003.0,"typeDisp":"Equity","longname":"Novartis AG","exchDisp":"Frankfurt","sector":"Healthcare","sectorDisp":"Healthcare","industry":"Drug Manufacturers—General","industryDisp":"Drug Manufacturers—General","isYahooFinance":true}],"news":[{"uuid":"1fd6a990-dc5c-3713-a21d-dc20e2f4a43d","title":"Novartis (NVS) to Report Q3 Earnings: What's in the Offing?","publisher":"Zacks","link":"https://finance.yahoo.com/news/novartis-nvs-report-q3-earnings-142000266.html","providerPublishTime":1697811600,"type":"STORY","thumbnail":{"resolutions":[{"url":"https://s.yimg.com/uu/api/res/1.2/k1h7Nf7YKXEJVG0fEMqg6A--~B/aD01ODc7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/d9b3f7b5ae7f67e58a203af36b3a7698","width":900,"height":587,"tag":"original"},{"url":"https://s.yimg.com/uu/api/res/1.2/sUwB5oBWgiU2ZSuVklARIA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/d9b3f7b5ae7f67e58a203af36b3a7698","width":140,"height":140,"tag":"140x140"}]},"relatedTickers":["NVS"]},{"uuid":"76a31855-22c7-32b4-ade2-9da4e1e6c7ff","title":"Novartis Kisqali® NATALEE analysis reinforces consistent reduction in risk of recurrence across key subgroups of patients with early breast cancer","publisher":"GlobeNewswire","link":"https://finance.yahoo.com/news/novartis-kisqali-natalee-analysis-reinforces-100000117.html","providerPublishTime":1697796000,"type":"STORY","thumbnail":{"resolutions":[{"url":"https://s.yimg.com/uu/api/res/1.2/U4MW90qm.LSQ.u9U1Bi62A--~B/aD01NTt3PTI4NzthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/d8d2f8bc436fea703ade9991085954e1","width":287,"height":55,"tag":"original"},{"url":"https://s.yimg.com/uu/api/res/1.2/4ZUrCpJgGCwLbcP_XfXFFw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/d8d2f8bc436fea703ade9991085954e1","width":140,"height":140,"tag":"140x140"}]},"relatedTickers":["NVS","NVSEF"]},{"uuid":"dc92e4be-d1d3-3686-b531-a097d2adb574","title":"Novartis (NVS) Stock Moves -0.4%: What You Should Know","publisher":"Zacks","link":"https://finance.yahoo.com/news/novartis-nvs-stock-moves-0-220018901.html","providerPublishTime":1697666418,"type":"STORY","thumbnail":{"resolutions":[{"url":"https://s.yimg.com/uu/api/res/1.2/64vRzkiY9LXGPrpW4r2GRQ--~B/aD00Njc7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b95cfdd8768bc3c4620e666dbcb0b248","width":900,"height":467,"tag":"original"},{"url":"https://s.yimg.com/uu/api/res/1.2/K_VbSLl5PAgBcdM4TzmL5A--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/b95cfdd8768bc3c4620e666dbcb0b248","width":140,"height":140,"tag":"140x140"}]},"relatedTickers":["NVS"]},{"uuid":"a2ae99b1-e41d-3e9a-aa65-c50d80a0c64f","title":"2 Biotech Stocks That Could Make You Richer","publisher":"Motley Fool","link":"https://finance.yahoo.com/m/a2ae99b1-e41d-3e9a-aa65-c50d80a0c64f/2-biotech-stocks-that-could.html","providerPublishTime":1697551620,"type":"STORY","thumbnail":{"resolutions":[{"url":"https://s.yimg.com/uu/api/res/1.2/EP.CMYvb.iA5NrSSmU5i3A--~B/aD0xNDE0O3c9MjEyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/motleyfool.com/aaf56d4e7cc5e59f40be22625aedc424","width":2120,"height":1414,"tag":"original"},{"url":"https://s.yimg.com/uu/api/res/1.2/KbLDGvV4UFV2hHV5r2mNtw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/aaf56d4e7cc5e59f40be22625aedc424","width":140,"height":140,"tag":"140x140"}]},"relatedTickers":["NVS","BMY"]},{"uuid":"1c93707b-46de-3bcb-bd46-1f4231eb5137","title":"3 Unstoppable Stocks to Buy and Hold for Decades","publisher":"Motley Fool","link":"https://finance.yahoo.com/m/1c93707b-46de-3bcb-bd46-1f4231eb5137/3-unstoppable-stocks-to-buy.html","providerPublishTime":1697533800,"type":"STORY","thumbnail":{"resolutions":[{"url":"https://s.yimg.com/uu/api/res/1.2/WOjyEjxsb8wHP_SPeJFSDA--~B/aD0xNDE0O3c9MjExOTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/motleyfool.com/f0143f5b9d8325a2b7819d3040ec6309","width":2119,"height":1414,"tag":"original"},{"url":"https://s.yimg.com/uu/api/res/1.2/0aMvEI07iR6zIEy2GxYEXQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/f0143f5b9d8325a2b7819d3040ec6309","width":140,"height":140,"tag":"140x140"}]},"relatedTickers":["NVS","V","MSFT"]},{"uuid":"19256874-0db8-3706-b4c9-98539ea50942","title":"Novartis (NVS) Suffers a Larger Drop Than the General Market: Key Insights","publisher":"Zacks","link":"https://finance.yahoo.com/news/novartis-nvs-suffers-larger-drop-220018675.html","providerPublishTime":1697148018,"type":"STORY","thumbnail":{"resolutions":[{"url":"https://s.yimg.com/uu/api/res/1.2/132juehTNIyEUn7pK7.GPA--~B/aD01MDY7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3d7c5b2146ac04ffd51752e17ff2a619","width":900,"height":506,"tag":"original"},{"url":"https://s.yimg.com/uu/api/res/1.2/twDpSkUZEyzUBc0qEMHAqw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/3d7c5b2146ac04ffd51752e17ff2a619","width":140,"height":140,"tag":"140x140"}]},"relatedTickers":["NVS"]},{"uuid":"24fbfb3c-4dbb-3c94-a8c9-e80e5ad5d16f","title":"Jasper (JSPR) Up on FDA Nod to Begin Early-Stage Urticaria Study","publisher":"Zacks","link":"https://finance.yahoo.com/news/jasper-jspr-fda-nod-begin-114400285.html","providerPublishTime":1696938240,"type":"STORY","thumbnail":{"resolutions":[{"url":"https://s.yimg.com/uu/api/res/1.2/YZV2sCaIvhJCeze571yj9A--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/f4319d7578dbbccc9017d5ec5d1c6947","width":635,"height":400,"tag":"original"},{"url":"https://s.yimg.com/uu/api/res/1.2/BFEIkxAz.yqOQBcpDqZqCw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/f4319d7578dbbccc9017d5ec5d1c6947","width":140,"height":140,"tag":"140x140"}]},"relatedTickers":["NVS","CORT"]},{"uuid":"abf8c8d1-511c-34fe-8532-7702043bf71d","title":"Novartis (NVS) Ascends But Remains Behind Market: Some Facts to Note","publisher":"Zacks","link":"https://finance.yahoo.com/news/novartis-nvs-ascends-remains-behind-220018927.html","providerPublishTime":1696629618,"type":"STORY","thumbnail":{"resolutions":[{"url":"https://s.yimg.com/uu/api/res/1.2/xMhOxlfdhVA7Ts3pP3IHyA--~B/aD02MzM7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b369e357aa3d42cc28ac674490d4ae83","width":900,"height":633,"tag":"original"},{"url":"https://s.yimg.com/uu/api/res/1.2/1wWgvR9AXA1o_EfTypadHw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/b369e357aa3d42cc28ac674490d4ae83","width":140,"height":140,"tag":"140x140"}]},"relatedTickers":["NVS"]}],"nav":[],"lists":[{"slug":"the-fight-against-covid19","name":"The Fight Against COVID19","index":"the-fight-against-covid19","score":6.7981253,"type":"ALGO_WATCHLIST","brandSlug":"trea","pfId":"the_fight_against_covid19","symbolCount":13,"dailyPercentGain":-0.5484158039151487,"followerCount":23761,"iconUrl":"https://edgecast-img.yahoo.net/mysterio/api/3c7c7b592c7aba2beee72abb1e520b85d6241aee639ea2e8033b96962ad2e126/finance/resizefill_w96_h96/https://s.yimg.com/uc/fin/img/iStock-476433472.png","userId":"X3NJ2A7VDSABUI4URBWME2PZNM"},{"slug":"aging-baby-boomers","name":"Aging Baby Boomers","index":"aging-baby-boomers","score":1.1108263,"type":"ALGO_WATCHLIST","brandSlug":"yahoo-finance","pfId":"aging_baby_boomers","symbolCount":11,"dailyPercentGain":-1.1072322303050244,"followerCount":3768,"iconUrl":"https://edgecast-img.yahoo.net/mysterio/api/5012864ca85a18365b8dc6a2de4e4ce17202e825c0df84f19bf009dff0353aff/finance/resizefill_w96_h96/https://s.yimg.com/dh/ap/finance/portfolio/aging-baby-boomers.jpg","userId":"X3NJ2A7VDSABUI4URBWME2PZNM"}],"researchReports":[],"screenerFieldResults":[],"totalTime":105,"timeTakenForQuotes":451,"timeTakenForNews":600,"timeTakenForAlgowatchlist":400,"timeTakenForPredefinedScreener":400,"timeTakenForCrunchbase":0,"timeTakenForNav":400,"timeTakenForResearchReports":0,"timeTakenForScreenerField":0,"timeTakenForCulturalAssets":0}